Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Briana C Canady"'
Autor:
Yen-Chun Liu, Gwendolyn M. Illar, Raniah Al Amri, Briana C. Canady, Bryan Rea, Svetlana A. Yatsenko, Julia T. Geyer
Publikováno v:
Modern Pathology. 35:625-631
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::114d0ded58e18463a33bbb455643925e
https://doi.org/10.1038/s41379-021-00958-9
https://doi.org/10.1038/s41379-021-00958-9
Publikováno v:
American Journal of Clinical Pathology.
ObjectivesIDH1 and IDH2 are among the most commonly mutated genes in myeloid neoplasms (MNs). It has been proposed that IDH2 R172 mutations (mR172) define a molecular subtype of acute myeloid leukemia (AML), but the clinicopathologic features of AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f513900ec13f58d259f210fcfdec3e73
https://doi.org/10.1093/ajcp/aqad019
https://doi.org/10.1093/ajcp/aqad019
Autor:
Yen-Chun, Liu, Gwendolyn M, Illar, Raniah, Al Amri, Briana C, Canady, Bryan, Rea, Svetlana A, Yatsenko, Julia T, Geyer
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 35(5)
Therapy-related myeloid neoplasm (t-MN) arising in patients with prior cytotoxic treatments is considered a distinct entity due to its unfavorable prognosis. Latencies between the initial cytotoxic therapy and the occurrence of t-MNs vary but usually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7ce6e6f410fe249ffa9082c293cfd1d
https://pubmed.ncbi.nlm.nih.gov/34873304
https://pubmed.ncbi.nlm.nih.gov/34873304